Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/44555
Title: Real-life data of luspatercept in lower-risk myelodysplastic syndromes advocate new research objectives
Authors: Heyrman, Bert
Meers, Stef
Sid, Selim
PUT, Natalie 
Theunissen , Koen
Van Eygen, Koen
De Beule, Nathan
Clauwaert, Maxime
Maes , Helena
Salembier, Alexander
Lemmens , Jan
Van De Velde, Ann
Selleslag, Dominik
Bouziotis, Jason
De Becker, Ann
Anguille, Sebastien
Issue Date: 2024
Publisher: WILEY
Source: eJHaem, 5 (5) , p. 1096 -1099
Notes: Heyrman, B (corresponding author), Ziekenhuis Netwerk Antwerpen, Dept Haematol, Lindendreef 1, B-2020 Antwerp, Belgium.
bert.heyrman@zna.be
Document URI: http://hdl.handle.net/1942/44555
DOI: 10.1002/jha2.1027
ISI #: 001328749900001
Rights: 2024 The Author(s). eJHaem published by British Society for Haematology and John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Category: A1
Type: Journal Contribution
Appears in Collections:Research publications

Show full item record

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.